A recent paper by Tess O’Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, was mentioned by Ilana Schlam, Breast Medical Oncologist at Dana-Farber Cancer Institute, on X:
“Great review led by Tess O’Meara on the available data and challenges of sequencing ADCs in breast cancer.”
Authors: Tess O’Meara, Paolo Tarantino, Stefania Morganti, Ilana Schlam, Ana Garrido-Castro, Sara Tolaney.
Ilana Schlam, MD, is a Breast Medical Oncologist at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Tufts University Medical Center. Her research focuses on precision medicine, drug development, and addressing healthcare disparities in breast cancer treatment and outcomes.
More posts featuring Ilana Schlam.